<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Insulin-requiring <z:mp ids='MP_0002055'>diabetes</z:mp> affects 25-50% of young adults with cystic <z:mp ids='MP_0003045'>fibrosis</z:mp> (CF) </plain></SENT>
<SENT sid="1" pm="."><plain>Although the cause of <z:mp ids='MP_0002055'>diabetes</z:mp> in CF is unknown, recent heritability studies in CF twins and siblings indicate that genetic modifiers play a substantial role </plain></SENT>
<SENT sid="2" pm="."><plain>We sought to assess whether genes conferring risk for <z:mp ids='MP_0002055'>diabetes</z:mp> in the general population may play a risk modifying role in CF </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We tested whether a family history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> affected <z:mp ids='MP_0002055'>diabetes</z:mp> risk in CF patients in 539 families in the CF Twin and Sibling family-based study </plain></SENT>
<SENT sid="4" pm="."><plain>A type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> susceptibility gene (transcription factor 7-like 2, or TCF7L2) was evaluated for association with <z:mp ids='MP_0002055'>diabetes</z:mp> in CF using 998 patients from the family-based study and 802 unrelated CF patients in an independent case-control study </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Family history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> increased the risk of <z:mp ids='MP_0002055'>diabetes</z:mp> in CF (OR 3.1; p = 0.0009) </plain></SENT>
<SENT sid="6" pm="."><plain>A variant in TCF7L2 associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (the T allele at rs7903146) was associated with <z:mp ids='MP_0002055'>diabetes</z:mp> in CF in the family study (p = 0.004) and in the case-control study (p = 0.02; combined p = 0.0002) </plain></SENT>
<SENT sid="7" pm="."><plain>In the family-based study, variation in TCF7L2 increased the risk of <z:mp ids='MP_0002055'>diabetes</z:mp> about three-fold (HR 1.75 per allele, 95% CI 1.3-2.4; p = 0.0006), and decreased the mean age at <z:mp ids='MP_0002055'>diabetes</z:mp> diagnosis by 7 years </plain></SENT>
<SENT sid="8" pm="."><plain>In CF patients not treated with systemic <z:chebi fb="1" ids="24261">glucocorticoids</z:chebi>, the effect of TCF7L2 was even greater (HR 2.9 per allele, 95% CI 1.7-4.9, p = 0.00011) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS/INTERPRETATION: A genetic variant conferring risk for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in the general population is a modifier of risk for <z:mp ids='MP_0002055'>diabetes</z:mp> in CF </plain></SENT>
</text></document>